The most important case since the Supreme Court upheld the constitutionality of the Affordable Care Act will determine the law's ability to function in states without their own exchanges.
Oral arguments in King v. Burwell will be heard March 4, 2015, according to a spokesperson for the US Supreme Court, who confirmed the state this afternoon. The case represents the most serious challenge to the Affordable Care Act since the high court affirmed its constitutionality in June 2012.
In King v. Burwell, the justices must determine whether the law allows those who receive coverage through the federal exchange, HealthCare.gov, to continue to receive premium subsidies despite a drafting error that appears to limit subsidies to those whose states set up their own exchanges.
To the surprise of drafters of the law, 36 states opted against setting up exchanges, which would render the law unable to effectively function of consumers in all those states were no longer able to receive assistance in paying premiums.
Tax credits are available to Americans who enrolled “through an exchange established by the state.” Challengers to the ACA argue that language means consumers who live in states without their own exchanges are ineligible to get the tax credits. So far, most states without exchanges have not moved to create them, the exception being an effort underway in Florida, whose primary objective is to expand Medicaid to those up to 138% of the poverty line.
Obama Administration officials, as well as the IRS, have asserted that the law’s creators clearly intended to offer coverage to as many people as possible, and that other sections of the law indicate that subsidies are permitted in states served by the federal exchange.
See more on Modern Healthcare
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Study Links COVID-19 Pandemic to Rise in Neoadjuvant Chemotherapy for Ovarian Cancer in US
April 17th 2024There was greater use of neoadjuvant chemotherapy among US patients with ovarian cancer (OC) during the COVID-19 pandemic to reduce potential COVID-19 exposure and cancer treatment-related complications.
Read More